Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Harper Government Announces Proposed New Marihuana for Medical Purposes Regulations


News provided by

Health Canada

Dec 16, 2012, 20:06 ET

Share this article

Share toX

Share this article

Share toX

Changes improve public safety, maintain patient access

VANCOUVER, BC, Dec. 16, 2012 /CNW/ - The Honourable Leona Aglukkaq, Minister of Health, announced today that after a broad consultation process, the Government of Canada intends to make changes to the way Canadians access marihuana for medical purposes.

"Current medical marihuana regulations have left the system open to abuse," said Minister Aglukkaq.  "We have heard real concerns from law enforcement, fire officials, and municipalities about how people are hiding behind these rules to conduct illegal activity, and putting health and safety of Canadians at risk.  These changes will make it far more difficult for people to game the system."

In the past decade, Health Canada's Marihuana Medical Access Program has grown exponentially, from under 500 authorized persons in 2002 to over 26,000 today.

This rapid increase has had unintended consequences for public health, safety and security as a result of allowing individuals to produce marihuana in their homes.

The proposed new regulations will protect the health, safety and security of Canadians and their communities by eliminating the production of marihuana in homes.

The Government will no longer produce and distribute marihuana for medical purposes, opening up the market to companies which meet strict security requirements.  Production will no longer take place in homes and municipal zoning laws will need to be respected, which will further enhance public safety.

The current Marihuana Medical Access Program costs Canadian taxpayers millions of dollars each year.  The $5/gram Health Canada charges to program participants who choose to purchase from the department is heavily subsidized.

"An average of one in 22 grow operations (legal and illegal) catch fire, which is 24 times higher than the average home," said Stephen Gamble, President of the Canadians Association of Fire Chiefs.  "We applaud the Government of Canada for strengthening Health Canada's regulations for marihuana for medical purposes to enhance the safety of Canada's firefighters and the communities they protect."

"Changes are necessary to reduce the risk of abuse and exploitation by criminal elements," said Chief Constable Jim Chu.  "We very much appreciate the collaborative relationship the Canadian Association of Chiefs of Police enjoys with Health Canada and how they are responding to the unintended public safety impact through the proposed changes to the Marihuana Medical Access Program."

In response to concerns from patients, the proposed new Marihuana for Medical Purposes Regulations aim to treat marihuana as much as possible like any other narcotic used for medical purposes.  Health care practitioners will be able to sign a medical document similar to a prescription, and then patients can purchase the appropriate amount from an authorized vendor.  The new system would cut red tape for individuals and ensure that they have access to marihuana for medical purposes produced under quality controls while streamlining the process for applicants and health care practitioners.

"These changes strike the right balance between patient access and public safety," said Minister Aglukkaq.

It is the Government's intention to fully implement this new system by March 31, 2014. On this date, all authorizations to possess and licences to produce issued under the current program would expire, and all individuals requiring marihuana for medical purposes would have to purchase it from licensed producers.

Details of the proposed new regulations are posted on our website. There will be a 75-day comment period and the Department will be receiving comments until February 28, 2013.  Health Canada will keep all stakeholders informed as we continue to move through the regulatory process.

Également disponible en français

Backgrounder - Proposed Marihuana for Medical Purposes Regulations - Transitioning to a New System

The Minister of Health has announced proposed regulations that would change the way Canadians access marihuana for medical purposes.  These proposed changes will not be finalized until the proposed Marihuana for Medical Purposes Regulations (MMPR) come into force (expected in spring 2013).  Until that time, individuals will continue to obtain authorization under the current Marihuana Medical Access Program.

Here are some key dates in the transition to the new system:

Winter 2012

  • Health Canada, through Public Works and Government Services Canada, will keep its contract with Prairie Plant Systems for the production and distribution of marihuana for medical purposes. This contract will run until March 31, 2014, and will make sure that program participants who choose to purchase dried marihuana from Health Canada will continue to have access to a legal supply of marihuana for medical purposes during the transition period.
  • Health Canada will inform interested parties that they may apply to become authorized to conduct certain research and development activities with marihuana now, including testing plant materials and growing conditions. These activities could help potential licensed producers to be ready to apply for a licence as soon as the proposed regulations come into force.

Spring 2013

  • The Marihuana for Medical Purposes Regulations (MMPR) are expected to come into force.
  • In order to facilitate the transition from the Marihuana Medical Access Program (MMAP) to the MMPR, both would operate concurrently from the time the new regulations come into force until March 31, 2014.  During that time, individuals could choose to continue to access marihuana for medical purposes under the MMAP or order directly from a licensed producer (as soon as they are approved by Health Canada).
  • Individuals would be allowed to use their Health Canada-issued authorization to possess or the medical declaration signed by their physician, for up to one year, to register with a licensed producer and place an order for dried marihuana from a licensed producer.  This would help make sure that patients can access dried marihuana and it would not be interrupted when the current program comes to an end.
  • Once the first established licensed producers have set a price for dried marihuana, Health Canada will align the price of its own supply.

October 1, 2013

  • For authorized users under the Marihuana Medical Access Program (MMAP), this system would begin to wind down.  Health Canada would no longer accept new applications under the MMAP for production licences or applications to change the location of a production site. This is because the time required to obtain seeds and produce a viable crop of marihuana for medical purposes is approximately six months and all production under the current program must end on March 31, 2014.
  • Health Canada would continue to renew personal use and designated production licences under the current MMAP.
  • Health Canada's supply would be available until March 31, 2014.  Supply provided by approved licensed producers, will also be available after the coming into force of the MMPR and will be the only source of supply after March 31, 2014.
  • For new applicants, after October 1, 2013, individuals requiring access to marihuana for medical purposes who do not already hold a valid production licence for a given site would either have to obtain dried marihuana from Health Canada (until March 31, 2014 only), or go directly to an approved licensed producer.

April 1, 2014

  • The new system is expected to be fully implemented and the MMAP would end.
  • All authorizations to possess and licences to produce issued under the current program would expire. Holders of personal use and designated person production licences would no longer be allowed to grow their own crop.
  • Health Canada would no longer produce or sell marihuana for medical purposes.
  • All individuals requiring access to marihuana for medical purposes would have to obtain it from a licensed producer. This competitive industry would set its own prices, choose to sell a variety of strains, and be subject to security requirements, inspections, and good manufacturing practices.

Backgrounder - Proposed Marihuana for Medical Purposes Regulations

Based on consultations with a broad range of stakeholders, the Government of Canada is concerned that the current Marihuana Medical Access Program is far too open to abuse.

While courts have ordered that there must be reasonable access to marihuana for medical purposes for patients that are seriously ill, this must be done in a controlled fashion in order to protect public safety.

The proposed Marihuana for Medical Purposes Regulations balance the needs of patients with public health, security and safety concerns.  These changes will strengthen the safety of Canadian communities, while making sure patients can access what they need to treat serious illnesses.

The new regulations' objective is to treat marihuana as much as possible like other narcotics used for medical purposes by:

  • Eliminating risky production of marihuana by individuals in their homes;
  • Ending Health Canada's role in authorizing individuals to possess and produce marihuana and in supplying and distributing marihuana; and
  • Creating conditions for the establishment of a regulated commercial market of licensed producers responsible for the production and distribution of marihuana for medical purposes.  These regulated licensed producers would have to meet extensive security and quality control requirements.
  • Patients would obtain a medical document, similar to a prescription, and purchase marihuana directly from a licensed producer.
  • Individuals would be able to obtain a medical document from a licensed medical practitioner, or, if permitted by provincial or territorial governments, from a nurse practitioner. If permitted by provinces and territories, pharmacists could also dispense marihuana directly to individuals.

The regulations would also streamline the process to obtain access to marihuana for medical purposes for individuals and improve the quality of this product by:

  • No longer requiring individuals to apply to Health Canada - and submit their personal medical information to the government - for authorization to access marihuana for medical purposes;
  • No longer requiring individuals to consult a specialist in addition to their health care practitioner;
  • Simplifying the process for health care practitioners to support access by removing the requirement to sign a medical declaration and fill out Health Canada forms;
  • Providing access to quality-controlled marihuana for medical purposes by requiring licensed producers to be subject to inspections and good production practices.

Backgrounder - Safety and Security Requirements for Licensed Producers

The Government of Canada is concerned that the current Marihuana Medical Access Program is vulnerable to abuse.  While the courts have said that there must be reasonable access to marihuana for medical purposes, the Government believes that this must be done in a controlled fashion in order to protect public safety.

The proposed Marihuana for Medical Purposes Regulations (MMPR) create the conditions for the establishment of a regulated commercial market of licensed producers responsible for the production and distribution of marihuana for medical purposes.  These regulated licensed producers would have to meet extensive security and quality control requirements. For example, when potential licensed producers apply to Health Canada for a license, they must demonstrate that:

  • They employ a quality assurance person with appropriate training, experience and technical knowledge to approve the quality of their dried marihuana;
  • Their production site is indoors, and not in a private dwelling.  This would reduce the risk of diversion posted by outdoor production and would reduce health and safety risks associated with producing marihuana in a private dwelling;
  • The production site includes restricted-access areas, which would include all areas where a licensed activity is conducted with marihuana and cannabis other than marihuana (i.e. lab, production room, etc);
  • Access to the production site is controlled at all times and includes 24/7 visual monitoring systems and an intrusion detection system to detect unauthorized access;
  • Key personnel hold a valid security clearance, issued by the Minister of Health; and,
  • They have provided a written notification of their application, providing details regarding the location of the production site, to the local police force, local fire authority and local government.

It will not be possible to apply to become a licensed producer until the proposed Marihuana for Medical Purposes Regulations come into effect.

However, interested parties may immediately apply to become authorized to conduct certain research and development activities with marihuana, including testing marihuana plant materials and growing conditions.  Beginning these research and development activities now may help potential licensed producers to be ready to apply for a licence when the regulations come into force.  However, authorisation to conduct research and development is not a guarantee that a producer will receive a licence under the proposed regulations. They would still have to demonstrate compliance with all of the regulatory requirements.

Interested parties can visit the Health Canada website for further information.

Image with caption: "Minister of Health, Leona Aglukkaq announces proposed new Marihuana for Medical Purposes Regulations in Maple Ridge, BC. (CNW Group/Health Canada)". Image available at: http://photos.newswire.ca/images/download/20121216_C9470_PHOTO_EN_21997.jpg

SOURCE: Health Canada

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.